Shopping Cart 0
Cart Subtotal
AED 0

Global Pembrolizumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Scope of the Report:

The worldwide market for Pembrolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Pembrolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Merck

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

50mg Injection

100mg Injection

Market Segment by Applications, can be divided into

Advanced Melanoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

Unresectable or Metastatic Solid Tumor

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pembrolizumab product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Pembrolizumab, with price, sales, revenue and global market share of Pembrolizumab in 2017 and 2018.

Chapter 3, the Pembrolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pembrolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Pembrolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Pembrolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Pembrolizumab Introduction

1.2 Market Analysis by Type

1.2.1 50mg Injection

1.2.2 100mg Injection

1.3 Market Analysis by Applications

1.3.1 Advanced Melanoma

1.3.2 Head and Neck Squamous Cell Carcinoma (HNSCC)

1.3.3 Unresectable or Metastatic Solid Tumor

1.3.4 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Pembrolizumab Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pembrolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Pembrolizumab Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Pembrolizumab Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Pembrolizumab Manufacturer Market Share in 2018

3.3.2 Top 6 Pembrolizumab Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Pembrolizumab Market Analysis by Regions

4.1 Global Pembrolizumab Sales, Revenue and Market Share by Regions

4.1.1 Global Pembrolizumab Sales and Market Share by Regions (2014-2019)

4.1.2 Global Pembrolizumab Revenue and Market Share by Regions (2014-2019)

4.2 North America Pembrolizumab Sales and Growth Rate (2014-2019)

4.3 Europe Pembrolizumab Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)

4.5 South America Pembrolizumab Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)

5 North America Pembrolizumab by Country

5.1 North America Pembrolizumab Sales, Revenue and Market Share by Country

5.1.1 North America Pembrolizumab Sales and Market Share by Country (2014-2019)

5.1.2 North America Pembrolizumab Revenue and Market Share by Country (2014-2019)

5.2 United States Pembrolizumab Sales and Growth Rate (2014-2019)

5.3 Canada Pembrolizumab Sales and Growth Rate (2014-2019)

5.4 Mexico Pembrolizumab Sales and Growth Rate (2014-2019)

6 Europe Pembrolizumab by Country

6.1 Europe Pembrolizumab Sales, Revenue and Market Share by Country

6.1.1 Europe Pembrolizumab Sales and Market Share by Country (2014-2019)

6.1.2 Europe Pembrolizumab Revenue and Market Share by Country (2014-2019)

6.2 Germany Pembrolizumab Sales and Growth Rate (2014-2019)

6.3 UK Pembrolizumab Sales and Growth Rate (2014-2019)

6.4 France Pembrolizumab Sales and Growth Rate (2014-2019)

6.5 Russia Pembrolizumab Sales and Growth Rate (2014-2019)

6.6 Italy Pembrolizumab Sales and Growth Rate (2014-2019)

7 Asia-Pacific Pembrolizumab by Country

7.1 Asia-Pacific Pembrolizumab Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Pembrolizumab Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Pembrolizumab Revenue and Market Share by Country (2014-2019)

7.2 China Pembrolizumab Sales and Growth Rate (2014-2019)

7.3 Japan Pembrolizumab Sales and Growth Rate (2014-2019)

7.4 Korea Pembrolizumab Sales and Growth Rate (2014-2019)

7.5 India Pembrolizumab Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)

8 South America Pembrolizumab by Country

8.1 South America Pembrolizumab Sales, Revenue and Market Share by Country

8.1.1 South America Pembrolizumab Sales and Market Share by Country (2014-2019)

8.1.2 South America Pembrolizumab Revenue and Market Share by Country (2014-2019)

8.2 Brazil Pembrolizumab Sales and Growth Rate (2014-2019)

8.3 Argentina Pembrolizumab Sales and Growth Rate (2014-2019)

8.4 Colombia Pembrolizumab Sales and Growth Rate (2014-2019)

9 Middle East and Africa Pembrolizumab by Countries

9.1 Middle East and Africa Pembrolizumab Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Pembrolizumab Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Pembrolizumab Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)

9.3 Turkey Pembrolizumab Sales and Growth Rate (2014-2019)

9.4 Egypt Pembrolizumab Sales and Growth Rate (2014-2019)

9.5 Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)

9.6 South Africa Pembrolizumab Sales and Growth Rate (2014-2019)

10 Global Pembrolizumab Market Segment by Type

10.1 Global Pembrolizumab Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Pembrolizumab Sales and Market Share by Type (2014-2019)

10.1.2 Global Pembrolizumab Revenue and Market Share by Type (2014-2019)

10.2 50mg Injection Sales Growth and Price

10.2.1 Global 50mg Injection Sales Growth (2014-2019)

10.2.2 Global 50mg Injection Price (2014-2019)

10.3 100mg Injection Sales Growth and Price

10.3.1 Global 100mg Injection Sales Growth (2014-2019)

10.3.2 Global 100mg Injection Price (2014-2019)

11 Global Pembrolizumab Market Segment by Application

11.1 Global Pembrolizumab Sales Market Share by Application (2014-2019)

11.2 Advanced Melanoma Sales Growth (2014-2019)

11.3 Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)

11.4 Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)

11.5 Other Sales Growth (2014-2019)

12 Pembrolizumab Market Forecast (2019-2024)

12.1 Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)

12.2 Pembrolizumab Market Forecast by Regions (2019-2024)

12.2.1 North America Pembrolizumab Market Forecast (2019-2024)

12.2.2 Europe Pembrolizumab Market Forecast (2019-2024)

12.2.3 Asia-Pacific Pembrolizumab Market Forecast (2019-2024)

12.2.4 South America Pembrolizumab Market Forecast (2019-2024)

12.2.5 Middle East and Africa Pembrolizumab Market Forecast (2019-2024)

12.3 Pembrolizumab Market Forecast by Type (2019-2024)

12.3.1 Global Pembrolizumab Sales Forecast by Type (2019-2024)

12.3.2 Global Pembrolizumab Market Share Forecast by Type (2019-2024)

12.4 Pembrolizumab Market Forecast by Application (2019-2024)

12.4.1 Global Pembrolizumab Sales Forecast by Application (2019-2024)

12.4.2 Global Pembrolizumab Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Pembrolizumab Picture

Table Product Specifications of Pembrolizumab

Figure Global Sales Market Share of Pembrolizumab by Types in 2018

Table Pembrolizumab Types for Major Manufacturers

Figure 50mg Injection Picture

Figure 100mg Injection Picture

Figure Pembrolizumab Sales Market Share by Applications in 2018

Figure Advanced Melanoma Picture

Figure Head and Neck Squamous Cell Carcinoma (HNSCC) Picture

Figure Unresectable or Metastatic Solid Tumor Picture

Figure Other Picture

Figure United States Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure France Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure UK Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure China Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure India Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Pembrolizumab Type and Applications

Table Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Pembrolizumab Sales by Manufacturer (2017-2018)

Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2017

Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2018

Table Global Pembrolizumab Revenue by Manufacturer (2017-2018)

Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2017

Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2018

Figure Top 3 Pembrolizumab Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Pembrolizumab Manufacturer (Revenue) Market Share in 2018

Figure Global Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Global Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Global Pembrolizumab Sales by Regions (2014-2019)

Table Global Pembrolizumab Sales Market Share by Regions (2014-2019)

Table Global Pembrolizumab Revenue by Regions (2014-2019)

Figure Global Pembrolizumab Revenue Market Share by Regions (2014-2019)

Figure Global Pembrolizumab Revenue Market Share by Regions in 2018

Figure North America Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Europe Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South America Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)

Figure North America Pembrolizumab Revenue and Growth Rate (2014-2019)

Table North America Pembrolizumab Sales by Countries (2014-2019)

Table North America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Sales Market Share by Countries in 2018

Table North America Pembrolizumab Revenue by Countries (2014-2019)

Table North America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Revenue Market Share by Countries in 2018

Figure United States Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Canada Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Mexico Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Europe Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Europe Pembrolizumab Sales by Countries (2014-2019)

Table Europe Pembrolizumab Sales Market Share by Countries (2014-2019)

Table Europe Pembrolizumab Revenue by Countries (2014-2019)

Figure Europe Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Europe Pembrolizumab Revenue Market Share by Countries in 2018

Figure Germany Pembrolizumab Sales and Growth Rate (2014-2019)

Figure UK Pembrolizumab Sales and Growth Rate (2014-2019)

Figure France Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Russia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Italy Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Pembrolizumab Sales by Countries (2014-2019)

Table Asia-Pacific Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Pembrolizumab Sales Market Share by Countries 2018

Table Asia-Pacific Pembrolizumab Revenue by Countries (2014-2019)

Figure Asia-Pacific Pembrolizumab Revenue Market Share by Countries 2018

Figure China Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Japan Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Korea Pembrolizumab Sales and Growth Rate (2014-2019)

Figure India Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South America Pembrolizumab Revenue and Growth Rate (2014-2019)

Table South America Pembrolizumab Sales by Countries (2014-2019)

Table South America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure South America Pembrolizumab Sales Market Share by Countries in 2018

Table South America Pembrolizumab Revenue by Countries (2014-2019)

Table South America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure South America Pembrolizumab Revenue Market Share by Countries in 2018

Figure Brazil Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Argentina Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Colombia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Pembrolizumab Sales by Countries (2014-2019)

Table Middle East and Africa Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Sales Market Share by Countries in 2018

Table Middle East and Africa Pembrolizumab Revenue by Countries (2014-2019)

Table Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries in 2018

Figure Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure UAE Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Egypt Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South Africa Pembrolizumab Sales and Growth Rate (2014-2019)

Table Global Pembrolizumab Sales by Type (2014-2019)

Table Global Pembrolizumab Sales Share by Type (2014-2019)

Table Global Pembrolizumab Revenue by Type (2014-2019)

Table Global Pembrolizumab Revenue Share by Type (2014-2019)

Figure Global 50mg Injection Sales Growth (2014-2019)

Figure Global 50mg Injection Price (2014-2019)

Figure Global 100mg Injection Sales Growth (2014-2019)

Figure Global 100mg Injection Price (2014-2019)

Table Global Pembrolizumab Sales by Application (2014-2019)

Table Global Pembrolizumab Sales Share by Application (2014-2019)

Figure Global Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)

Figure Global Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)

Table Global Pembrolizumab Sales Forecast by Regions (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Regions (2019-2024)

Figure North America Sales Pembrolizumab Market Forecast (2019-2024)

Figure Europe Sales Pembrolizumab Market Forecast (2019-2024)

Figure Asia-Pacific Sales Pembrolizumab Market Forecast (2019-2024)

Figure South America Sales Pembrolizumab Market Forecast (2019-2024)

Figure Middle East and Africa Sales Pembrolizumab Market Forecast (2019-2024)

Table Global Pembrolizumab Sales Forecast by Type (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Type (2019-2024)

Table Global Pembrolizumab Sales Forecast by Application (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Merck

Company Profile

Company Profile Title

Scope of the Report:

The worldwide market for Pembrolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Pembrolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Merck

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

50mg Injection

100mg Injection

Market Segment by Applications, can be divided into

Advanced Melanoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

Unresectable or Metastatic Solid Tumor

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pembrolizumab product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Pembrolizumab, with price, sales, revenue and global market share of Pembrolizumab in 2017 and 2018.

Chapter 3, the Pembrolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pembrolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Pembrolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Pembrolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Pembrolizumab Introduction

1.2 Market Analysis by Type

1.2.1 50mg Injection

1.2.2 100mg Injection

1.3 Market Analysis by Applications

1.3.1 Advanced Melanoma

1.3.2 Head and Neck Squamous Cell Carcinoma (HNSCC)

1.3.3 Unresectable or Metastatic Solid Tumor

1.3.4 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Pembrolizumab Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pembrolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Pembrolizumab Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Pembrolizumab Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Pembrolizumab Manufacturer Market Share in 2018

3.3.2 Top 6 Pembrolizumab Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Pembrolizumab Market Analysis by Regions

4.1 Global Pembrolizumab Sales, Revenue and Market Share by Regions

4.1.1 Global Pembrolizumab Sales and Market Share by Regions (2014-2019)

4.1.2 Global Pembrolizumab Revenue and Market Share by Regions (2014-2019)

4.2 North America Pembrolizumab Sales and Growth Rate (2014-2019)

4.3 Europe Pembrolizumab Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)

4.5 South America Pembrolizumab Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)

5 North America Pembrolizumab by Country

5.1 North America Pembrolizumab Sales, Revenue and Market Share by Country

5.1.1 North America Pembrolizumab Sales and Market Share by Country (2014-2019)

5.1.2 North America Pembrolizumab Revenue and Market Share by Country (2014-2019)

5.2 United States Pembrolizumab Sales and Growth Rate (2014-2019)

5.3 Canada Pembrolizumab Sales and Growth Rate (2014-2019)

5.4 Mexico Pembrolizumab Sales and Growth Rate (2014-2019)

6 Europe Pembrolizumab by Country

6.1 Europe Pembrolizumab Sales, Revenue and Market Share by Country

6.1.1 Europe Pembrolizumab Sales and Market Share by Country (2014-2019)

6.1.2 Europe Pembrolizumab Revenue and Market Share by Country (2014-2019)

6.2 Germany Pembrolizumab Sales and Growth Rate (2014-2019)

6.3 UK Pembrolizumab Sales and Growth Rate (2014-2019)

6.4 France Pembrolizumab Sales and Growth Rate (2014-2019)

6.5 Russia Pembrolizumab Sales and Growth Rate (2014-2019)

6.6 Italy Pembrolizumab Sales and Growth Rate (2014-2019)

7 Asia-Pacific Pembrolizumab by Country

7.1 Asia-Pacific Pembrolizumab Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Pembrolizumab Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Pembrolizumab Revenue and Market Share by Country (2014-2019)

7.2 China Pembrolizumab Sales and Growth Rate (2014-2019)

7.3 Japan Pembrolizumab Sales and Growth Rate (2014-2019)

7.4 Korea Pembrolizumab Sales and Growth Rate (2014-2019)

7.5 India Pembrolizumab Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)

8 South America Pembrolizumab by Country

8.1 South America Pembrolizumab Sales, Revenue and Market Share by Country

8.1.1 South America Pembrolizumab Sales and Market Share by Country (2014-2019)

8.1.2 South America Pembrolizumab Revenue and Market Share by Country (2014-2019)

8.2 Brazil Pembrolizumab Sales and Growth Rate (2014-2019)

8.3 Argentina Pembrolizumab Sales and Growth Rate (2014-2019)

8.4 Colombia Pembrolizumab Sales and Growth Rate (2014-2019)

9 Middle East and Africa Pembrolizumab by Countries

9.1 Middle East and Africa Pembrolizumab Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Pembrolizumab Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Pembrolizumab Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)

9.3 Turkey Pembrolizumab Sales and Growth Rate (2014-2019)

9.4 Egypt Pembrolizumab Sales and Growth Rate (2014-2019)

9.5 Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)

9.6 South Africa Pembrolizumab Sales and Growth Rate (2014-2019)

10 Global Pembrolizumab Market Segment by Type

10.1 Global Pembrolizumab Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Pembrolizumab Sales and Market Share by Type (2014-2019)

10.1.2 Global Pembrolizumab Revenue and Market Share by Type (2014-2019)

10.2 50mg Injection Sales Growth and Price

10.2.1 Global 50mg Injection Sales Growth (2014-2019)

10.2.2 Global 50mg Injection Price (2014-2019)

10.3 100mg Injection Sales Growth and Price

10.3.1 Global 100mg Injection Sales Growth (2014-2019)

10.3.2 Global 100mg Injection Price (2014-2019)

11 Global Pembrolizumab Market Segment by Application

11.1 Global Pembrolizumab Sales Market Share by Application (2014-2019)

11.2 Advanced Melanoma Sales Growth (2014-2019)

11.3 Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)

11.4 Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)

11.5 Other Sales Growth (2014-2019)

12 Pembrolizumab Market Forecast (2019-2024)

12.1 Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)

12.2 Pembrolizumab Market Forecast by Regions (2019-2024)

12.2.1 North America Pembrolizumab Market Forecast (2019-2024)

12.2.2 Europe Pembrolizumab Market Forecast (2019-2024)

12.2.3 Asia-Pacific Pembrolizumab Market Forecast (2019-2024)

12.2.4 South America Pembrolizumab Market Forecast (2019-2024)

12.2.5 Middle East and Africa Pembrolizumab Market Forecast (2019-2024)

12.3 Pembrolizumab Market Forecast by Type (2019-2024)

12.3.1 Global Pembrolizumab Sales Forecast by Type (2019-2024)

12.3.2 Global Pembrolizumab Market Share Forecast by Type (2019-2024)

12.4 Pembrolizumab Market Forecast by Application (2019-2024)

12.4.1 Global Pembrolizumab Sales Forecast by Application (2019-2024)

12.4.2 Global Pembrolizumab Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Pembrolizumab Picture

Table Product Specifications of Pembrolizumab

Figure Global Sales Market Share of Pembrolizumab by Types in 2018

Table Pembrolizumab Types for Major Manufacturers

Figure 50mg Injection Picture

Figure 100mg Injection Picture

Figure Pembrolizumab Sales Market Share by Applications in 2018

Figure Advanced Melanoma Picture

Figure Head and Neck Squamous Cell Carcinoma (HNSCC) Picture

Figure Unresectable or Metastatic Solid Tumor Picture

Figure Other Picture

Figure United States Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure France Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure UK Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure China Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure India Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Pembrolizumab Type and Applications

Table Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Pembrolizumab Sales by Manufacturer (2017-2018)

Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2017

Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2018

Table Global Pembrolizumab Revenue by Manufacturer (2017-2018)

Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2017

Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2018

Figure Top 3 Pembrolizumab Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Pembrolizumab Manufacturer (Revenue) Market Share in 2018

Figure Global Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Global Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Global Pembrolizumab Sales by Regions (2014-2019)

Table Global Pembrolizumab Sales Market Share by Regions (2014-2019)

Table Global Pembrolizumab Revenue by Regions (2014-2019)

Figure Global Pembrolizumab Revenue Market Share by Regions (2014-2019)

Figure Global Pembrolizumab Revenue Market Share by Regions in 2018

Figure North America Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Europe Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South America Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)

Figure North America Pembrolizumab Revenue and Growth Rate (2014-2019)

Table North America Pembrolizumab Sales by Countries (2014-2019)

Table North America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Sales Market Share by Countries in 2018

Table North America Pembrolizumab Revenue by Countries (2014-2019)

Table North America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure North America Pembrolizumab Revenue Market Share by Countries in 2018

Figure United States Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Canada Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Mexico Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Europe Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Europe Pembrolizumab Sales by Countries (2014-2019)

Table Europe Pembrolizumab Sales Market Share by Countries (2014-2019)

Table Europe Pembrolizumab Revenue by Countries (2014-2019)

Figure Europe Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Europe Pembrolizumab Revenue Market Share by Countries in 2018

Figure Germany Pembrolizumab Sales and Growth Rate (2014-2019)

Figure UK Pembrolizumab Sales and Growth Rate (2014-2019)

Figure France Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Russia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Italy Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Pembrolizumab Sales by Countries (2014-2019)

Table Asia-Pacific Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Pembrolizumab Sales Market Share by Countries 2018

Table Asia-Pacific Pembrolizumab Revenue by Countries (2014-2019)

Figure Asia-Pacific Pembrolizumab Revenue Market Share by Countries 2018

Figure China Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Japan Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Korea Pembrolizumab Sales and Growth Rate (2014-2019)

Figure India Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South America Pembrolizumab Revenue and Growth Rate (2014-2019)

Table South America Pembrolizumab Sales by Countries (2014-2019)

Table South America Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure South America Pembrolizumab Sales Market Share by Countries in 2018

Table South America Pembrolizumab Revenue by Countries (2014-2019)

Table South America Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure South America Pembrolizumab Revenue Market Share by Countries in 2018

Figure Brazil Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Argentina Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Colombia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Pembrolizumab Sales by Countries (2014-2019)

Table Middle East and Africa Pembrolizumab Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Sales Market Share by Countries in 2018

Table Middle East and Africa Pembrolizumab Revenue by Countries (2014-2019)

Table Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries in 2018

Figure Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)

Figure UAE Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Egypt Pembrolizumab Sales and Growth Rate (2014-2019)

Figure Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)

Figure South Africa Pembrolizumab Sales and Growth Rate (2014-2019)

Table Global Pembrolizumab Sales by Type (2014-2019)

Table Global Pembrolizumab Sales Share by Type (2014-2019)

Table Global Pembrolizumab Revenue by Type (2014-2019)

Table Global Pembrolizumab Revenue Share by Type (2014-2019)

Figure Global 50mg Injection Sales Growth (2014-2019)

Figure Global 50mg Injection Price (2014-2019)

Figure Global 100mg Injection Sales Growth (2014-2019)

Figure Global 100mg Injection Price (2014-2019)

Table Global Pembrolizumab Sales by Application (2014-2019)

Table Global Pembrolizumab Sales Share by Application (2014-2019)

Figure Global Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)

Figure Global Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)

Table Global Pembrolizumab Sales Forecast by Regions (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Regions (2019-2024)

Figure North America Sales Pembrolizumab Market Forecast (2019-2024)

Figure Europe Sales Pembrolizumab Market Forecast (2019-2024)

Figure Asia-Pacific Sales Pembrolizumab Market Forecast (2019-2024)

Figure South America Sales Pembrolizumab Market Forecast (2019-2024)

Figure Middle East and Africa Sales Pembrolizumab Market Forecast (2019-2024)

Table Global Pembrolizumab Sales Forecast by Type (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Type (2019-2024)

Table Global Pembrolizumab Sales Forecast by Application (2019-2024)

Table Global Pembrolizumab Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Merck